Q2 2017 Holdings
Filed 2017-08-14 | 8 holdings | $96.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Selecta Biosciences, Inc.(SELBUSD) | Common Stock | 816212104 | $38.2K | 1,924,151 | 39.5% |
| Cerulean Pharma Inc | Common Stock | 15708Q105 | $14.6K | 3,287,529 | 15.1% |
| Genocea Biosciences, Inc. | Common Stock | 372427104 | $10.3K | 1,968,606 | 10.6% |
| Pulmatrix Inc. | Common Stock | 74584P103 | $8.6K | 3,607,996 | 8.9% |
| Fate Therapeutics, Inc.(FATE) | Common Stock | 31189P102 | $8.0K | 2,473,186 | 8.3% |
| Atyr Pharma Inc.(LIFEUSD) | Common Stock | 002120103 | $6.2K | 1,827,992 | 6.4% |
| T2 Biosystems, Inc. | Common Stock | 89853L104 | $6.0K | 1,875,524 | 6.2% |
| Trevena, Inc. | Common Stock | 89532E109 | $4.7K | 2,053,540 | 4.9% |